Bioheng Therapeutics Receives FDA RPDD for Off‑The‑Shelf CAR‑T CTD402
Bioheng Therapeutics (China) announced that the U.S. Food and Drug Administration (FDA) has granted Rare...
Bioheng Therapeutics
Kactus Biosystems Partners with Bioheng for Cell Therapy Raw Materials
Shanghai-based Kactus Biosystems, a firm specializing in target proteins and raw enzymes, has announced a...